Spain· ES:90544
LEUSTATIN 2 MG/ML SOLUCION INYECTABLE
A medicinal product containing cladribina, registered in Spain by Atnahs Pharma Netherlands Bv..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- cladribina
- Manufacturer
- Atnahs Pharma Netherlands Bv.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cladribina in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLEUJECTAtnahs Pharma Netherlands B.V., Amsterdam
- PolandLeujectAtnahs Pharma Netherlands B.V.
- SwedenLeuject 2 mg/ml Injektionsvätska, lösningAtnahs Pharma Netherlands B.V.
- SwitzerlandLitak 10, Injektions- / InfusionslösungLipomed AG
- IcelandLitakLipomed GmbH*
- BelgiumLitak 2 mg/mlLipomed
- NorwayLitakLipomed GmbH
- United StatesCladribineSandoz Inc.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Leuject
- Belgium · Leustatin
- Bulgaria · Леуджект
- Czechia · Leuject
- Germany · Leustatin
- Finland · Leuject
- France · Leustatine
- United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
- Greece · Leustatin
- Croatia · Leuject
- Hungary · Leuject
- Iceland · Mavenclad
- Italy · Leustatin
- Liechtenstein · Mavenclad
- Luxembourg · Leustatin
- Netherlands · Leustatin
- Norway · Leuject, Mavenclad
- Poland · Biodribin, Leuject
- Portugal · Cladribina Generis, Leustatin
- Romania · Leuject
- Sweden · Leuject
- Slovenia · Leuject
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb67439f-ccbf-41ac-bbed-7ea59635a920 GET /v1/drugs/cb67439f-ccbf-41ac-bbed-7ea59635a920?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1757068646000}",
"nregistro": "90544",
"substance": "cladribina"
}See everything about cladribina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.